To study anorexia in chronic renal failure patients (CRF), we measured appetite-related hormones in 7 CRF patients and 4 controls. Plasma concentrations and fractional changes from baseline (values from Day 1, 08 hour) are listed as control versus CRF (means±SEM). Leptin, ng/ml, though higher in CRF, 5.6 ± 1.7 and 34 ± 17, was suppressed after fasting; decrements were -51 ± 9 % and -55 ± 8 %. Nocturnal surge present during feeding was abolished upon fasting in both groups. Neuropeptide Y (NPY, pg/ml) was elevated in CRF, 72 ± 12 versus 304 ± 28 (p=0.0002). NPY rhythm, reciprocal to that of leptin, was muted in CRF. Basal cortisol, ug/dl, was similar in both groups, 17 ± 3 and 17 ± 2. In the controls, cortisol peaked in the morning and declined in the evening. CRF showed blunted cortisol suppression.
INTRODUCTION
Malnutrition is prevalent in chronic renal failure [CRF] patients and anorexia is likely an important contributing factor (3) . It has been reported that food consumption declines as renal function deteriorates (14) . When uremia becomes severe, anorexia is believed to be prevalent, and is characterized by food aversion, early satiety and, sometimes, nausea and vomiting. Despite the prevalence of these symptoms, their pathogenesis has never been explained. We hypothesized that uremia-related anorexia may result from hypothalamic dysfunction. Renal failure patients are known to have a number of hormonal abnormalities due to hypothalamic disturbances; examples include diminished pulsatile gonadotropin and growth hormone secretion, lack of positive feedback effect of estrogen on LH secretion, excessive prolactin production and delayed puberty (18). Because eating is, by and large, a central nervous systemregulated event (11), we studied some of the appetite-related hormones in response to fasting and refeeding in chronic renal failure patients. The results were compared to those obtained from normal subjects. We wondered if CRF patients may have too much leptin or perhaps their leptin is not suppressed with food deprivation. We considered that these patients might be deficient in neuropeptide Y, [NPY] , a potent orexigenic peptide that mediates the effect of leptin in the hypothalamus (11) . Knowing that 4 normal controls consist of one woman and three men, ages 32 to 63 years. The CRF group consists of two pre-dialysis, four hemodialysis, and one peritoneal dialysis patients. There were one woman and six men aged 31 to 56. The two pre-dialysis patients were initiated into maintenance dialysis because of high serum creatinine; they did not specifically complain of anorexia. Diagnoses of the CRF patients included two with hypertensive nephrosclerosis, one Alport's disease, two with focal segmental glomerulosclerosis and one each with interstitial nephritis and immunotactoid glomerulopathy. No patients had diabetes or other concomitant systemic disease. All studies were conducted when the subjects were clinically stable and without intercurrent illness. Hemodialysis was performed three times weekly using CT190G dialyzers; KT/V ranged from 1.3 to 1.5. The single PD patient used the Fresenius PD plus system; he did five exchanges nocturnally plus one exchange during the daytime. His weekly KT/V was 2.75 and creatinine clearance, 53 L/week.
Upon recruitment, subjects made one visit to the GCRC [General Clinical Research Center] dietitian
for a dietary interview and anthropometric measurements. A subjective global assessment was also performed at that time. A menu was then created for each subject based on his/her routine intake and preference. The reason for this dietary step is to insure that the participants were eating regularly for at least two days prior to the study. Figure 1 is a time line representation of the experiment showing that subjects ate the CRC-prepared diet on Day -1 and Day 0. They were admitted to the GCRC in the afternoon of Day 0 when a heparin lock was placed for blood draws and a snack was given at 20 hour.
Following this, food was withheld for 37 hours until 09 hour of Day 2. During the fast, water was allowed ad lib. Subjects were encouraged to maintain their routine physical activities as much as permitted by the schedule of the blood draws. Re-feeding then followed and subjects were studied till 08 hour of Day 3.
During re-feeding, the menu remained constant, but portion sizes were ad lib per subjects' request. The amount of food ingested before fasting and during re-feeding was recorded. Blood was taken at 20 hour on Day 0, and on 00, 03, 08, 13, 18 and 20 hours on the other days. All blood samples were centrifuged immediately, the plasma frozen at -60º, and thawed at the time of assay. Leptin, neuropeptide Y [NPY], cortisol and ACTH were measured in all samples, while insulin and glucose only in samples as indicated in Figure 4 . Visual analogue scales assessing appetite and hunger were obtained at designated times during waking hours as depicted in Figure 5 .
Laboratory Procedures
Leptin was measured by radioimmunoassay using the Linco kits [ Center of the University of Iowa College of Medicine approved the entire protocol, and every study subject signed the consent form. Energy intake was 31.9 ± 1.8 and 31.2 ± 2.8 before fasting and 35.7 ± 2.5 and 39.7 ± 2.8 after the fast.
RESULTS
Protein intake was 1.24 ± 0.08 and 0.89 ± 0.06 [p=0.006] before the fast, higher in the normal subjects, and 1.48 ± 0.16 and 1.19 ± 0.11 after the fast. While both study groups increased food intake post fasting, only in the CRF patients were the differences between pre-and post fast statistically significant; p values were 0.05 and 0.03, respectively, for calorie and protein intake.
While mean leptin, ACTH and insulin values were higher in CRF patients; the differences did not reach statistical significance. This is because high values were present only in a few CRF patients. As shown in Tables 1 and 2 Table 3 . In normal subjects, on Day 1, 03 hour, leptin peaked to 7.7 ± 2.2, on the same day at 08 hour [baseline], the value was 5.6 ± 1.7. On Day 3, 03 hour, leptin reached a height of 10.2 ± 3.5. Leptin peaked at nocturnal times on both days. During the 37 hour fast, nocturnal surge was totally obliterated, and plasma leptin dipped to a nadir of 2.3 ± 0.4 at 03 hour, Day 2, and remained low at 2.5 ± 0.6 at 09 hour, Day 2 when the fast ended. In the CRF patients, plasma leptin was higher than that of the controls at all times during the experiment, but the difference never achieved statistical significance. Baseline leptin was 34.1 ± 17.4.
Nocturnal rise was less prominent compared to the controls. On Day 1, plasma leptin increased slightly to 36.4 ± 17.7 at 00 hour, and on Day 3, the highest nocturnal value was only 30.3 ± 12.0, at 03 hour. During the 37-hour fast, plasma leptin did fall to 12.7 ± 6.7 at 09 hour on Day 2 and remained low, 10.5 ± 4.9, at 13 hour that same day. hour, Day 1. During the re-feeding period, nocturnal surge reached levels of 61 ± 10% and 82 ± 14% above baseline, respectively, at 00 and 03 hours, Day 3. During fasting, nocturnal surge was totally abolished, and leptin dropped to a nadir of -53 ± 11% below baseline at 03 hour, Day 2, and was -51 ± 9 % of baseline at the end of the fast at 09 hour, Day 2. In the CRF patients, fasting also effectively suppressed leptin; nadir at the end of the fast was -55 ± 6 % at 09 hour, Day 2. The nocturnal surge during regular feeding was, however, blunted. On Day 1, the highest leptin increment was 13 ± 11%, noted at 03 hour. On Day 3, during re-feeding, the increments were 9 ± 11% at 00 hour [p=0.01] and 30 ± 14% [p = 0.04] at 03 hour. As we scrutinized the data, it became evident that this blunted nocturnal surge found in CRF patients was present only in the three CRF patients who had high body mass indices and whose basal leptins were high. Table 2 lists the CRF patients in accordance to their basal serum leptin levels.
Patients # 1, 3 and 7 had high, whereas patients # 2, 4, 5 and 6, normal basal leptin. During feeding, nocturnal leptin surge was brisk and unequivocal in those patients with normal leptin, but was blunted in those with high basal leptin. Fasting, on the other hand, suppressed leptin universally, whether basal levels were high or normal.
Listed in the right half of Table 3 is plasma NPY [pg/ml] at different times during the experiment. The values are about five-fold higher in the CRF patients at all times. In the normal subjects, higher values were found in the morning, between 08 and 09 hours, the values were 72 ± 12 on Day 1, 56 ± 15 on Day 2 and 73 ± 7 on Day 3. The nadir for these three days occurred at 00 hour, and the values were 51 ± 8, 28 ± 8 and 44 ± 11, respectively. The nocturnal decline in NPY was exaggerated during fasting, 28 on Day 2 versus 51 and 44 on Days 1 and 3. This NPY circadian rhythm was much muted in the CRF patients.
Corresponding morning values for Days 1, 2 and 3 were, respectively, 304 ± 28, 262 ±23 and 289 ± 23, and values at 00 hours for the same three days were 286 ± 29, 242 ± 24 and 245 ± 31. Table 1 ]. The diurnal ACTH concentration pattern is similar in both study groups, levels tend to be higher in the morning hours, coincided with or shortly before the cortisol peaks. In the normal subjects, peak values were 24.9 ± 5.5 on hours. The peak tended to occur earlier, at 03 hours, in control subjects.
Figures 3 A and B illustrate the circadian rhythm of cortisol and ACTH. In the normal subjects, plasma cortisol was highest in the morning, 08-09 hours, and lowest in the evening hours. Listed in the sequence of control versus CRF patients, fractional decrements from baseline were -70 ± 7 % and -29 ± As for ACTH, the peaks and troughs coincided or preceded those of plasma cortisol. Diurnal rhythm was present and not different between controls and CRF patients with one exception, and that was on Day 2, 03 hour during fasting. At that time, plasma ACTH rose by 51 ± 14% above baseline in the normal subjects, and fell by -34 ± 14 % in the CRF patients [p = 0.002]. This apparent dramatic difference at that particular time was due to a coincidental combination of earlier onset of morning peak in the normal subjects, 03 hour as compared to 0900 in the CRF patients, combined with a higher baseline value in CRF subjects [ Table 4 ]. In the three CRF patients with very high baseline ACTH, their fractional diurnal changes from baseline were not different from the four patients with normal basal ACTH.
Insulin/glucose Axis: Table 5 lists the data on insulin and glucose during the experiment. Plasma insulin was higher in the CRF patients at all times, but none reached statistical significance. Insulin levels were highest in the two male patients with high leptin, but the female patient with very high leptin and increased body fat content had normal plasma insulin [ Table 1 ]. Fasting reduced plasma insulin from baseline of 6.4 ± 0.9 to 1.2 ± 0.3 in normal subjects, and 20.0 ± 8.5 to 6.8 ± 3.2 in CRF patients. Post feeding, plasma insulin rose to 23.8 ± 5.9 in the controls and 85.5 ± 44.7 in the CRF patients. Plasma glucose decreased from 94 ± 4 to 77 ± 7 in the controls and 99 ± 4 to 87 ± 5 in the CRF patients during fasting and rose to 119 ± 5 in controls and 141 ± 9 in CRF patients during refeeding. Figure 4 illustrates insulin and glucose responses to fasting and feeding in the study groups. In normal controls, fractional decrements of plasma insulin during fasting were -81 ± 6% and -64 ± 0%, respectively, at 20 hour of Day 1 and 09 hour of Day 2, corresponding values in the CRF patients were -52 ± 13% and -51 ± 9%. In the refeeding period, fractional increments of plasma insulin reached peaks of 277 ± 96% and 397 ± 75%, respectively, in the normal and CRF subjects at 20 hour, Day 2. None of these oscillations were different between the two study groups. As for plasma glucose, the fractional decrements during fasting were -19 ± 4% in the normal subjects, and -12 ± 4% in the CRF patients at 09 hr on Day 2. Upon refeeding, fractional glucose increments were 26 ± 6% and 44 ± 12%, respectively, in the controls and the CRF patients, on 20 hr, Day 2. The responses were also similar in magnitude in the two study groups.
To assess whether high intra-individual variation and overlapping values might mask actual differences in the hormones examined in the two groups, we calculated the intra-individual coefficient of variations [COV, %] of all the studied hormones. Due to the circadian variation and the physiologic changes to feeding, we included only appropriate samples for the calculation of the COV. Nutritional status and appetite assessmentThe BMI and % body fat were comparable in the two study groups [ Table 1 ]. Subjective global assessment identified all subjects to be well nourished; all participants had a score of A. There were no adverse gastro-intestinal symptoms and no acute change in body weight. Physical examination did not detect any acute loss of fat or muscle wasting. All participants were fully functional in their usual activities. As for appetite assessment, the visual analogue scale showed that nausea was a rare occurrence.
The sensation of feeling hungry and the desire to eat were comparable in both study groups. The sensation of fullness was appropriately reciprocal to that of hunger. Figure 5 illustrates the hunger scores of the two study groups during the entire experiment. The hunger score peaked at Day 2, 09 hour [the end of fasting] in both groups; the scores were 9.8 ± 0.3 and 8.6 ± 0.9, respectively, in the controls and the CRF patients.
The hunger scores were similarly lowest for both groups at 20 hour, Day 0; the scores were 1.0 ± 0.6 and 3.4 ± 0.6, respectively, in the normal subjects and the CRF patients. None of these values were different between the two groups. The desire to eat scores parallels those of the hunger scores in both groups.
DISCUSSIONS
All the hormones studied in this experiment demonstrate either striking changes to fasting and feeding or some patterns of circadian change. Baseline serum leptin was not statistically different between the two groups. In normal subjects, there was an unequivocal nocturnal leptin surge and fasting profoundly suppressed leptin secretion. Sinha et al first reported nocturnal leptin rise in humans by measuring leptin in one 24-hour cycle (36). Pratley and colleagues did not detect any nocturnal rise when they measured leptin during a 24-hour fast (26) . During a 22-hour fast, Klein et al found a reduction in abdominal wall subcutaneous leptin production and this was accompanied by a parallel decline in circulating leptin (16) .
In the current study, we measured leptin during a 56-hour experiment consisting of pre-fast, fast and refeeding periods. We not only confirmed the nocturnal surge, but also found that fasting totally abolished this nocturnal rise. These findings suggest that the observed rise in serum leptin at night is a consequence of feeding during the day and not simply being linked to a diurnal rhythm. In rats, Saladin et al found ob gene expression to be related to feeding as well, and gene expression increased during the night when rats ate. When food was withheld, the nocturnal increase in ob mRNA was abolished (32) . In humans, serum leptin increased at around 00 hour, twenty hours following breakfast and four hours after the evening snack. In the rats, white adipose tissue ob gene increment also occurs at about 00 hour, 4 hours after feeding initiation. Sinha et al stated that the discrepancy between man and rat maybe due to species difference. We hypothesized that the discrepancy in time of onset of leptin peak could be explained by the lag time between increase in ob gene expression in the white adipose tissue and the rise in circulating level. The former was measured in the rat and the latter, man.
Qualitatively, the leptin response to fasting and feeding was similar in the two study groups.
Quantitatively, Figure 2 indicates that the nocturnal surge during feeding was diminished in CRF patient, but as shown in Table 2 , this blunting was present only in the three subjects who had excessive body fat content and high basal leptin. The other 4 patients with normal basal leptin behaved exactly like the control subjects showing an unequivocal nocturnal surge. We suspect that it is the increase in body fat, and not uremia, that led to the altered post-feeding leptin metabolism in these three obese CRF patients. In Sinha's study, nocturnal leptin surge was of milder magnitude in obese subjects (36). Klein and colleagues similarly found that leptin production from abdominal fat was less marked in obese compared to lean women (16) .
Several investigators reported that circulating leptin, factored for body mass index, was increased in CRF patients (34, 13) . It was suggested that the increased serum leptin is related to ongoing inflammation and maybe contributing to anorexia (13) . Our data do not show disproportionate elevation of leptin beyond that accounted for by body fat content. And because leptin was so effectively suppressed during food deprivation, it is unlikely to be the cause of uremic anorexia.
Circulating NPY levels were homogenously and markedly elevated in the CRF patients. This high level of NPY is unlikely to be due to assay problem as the antibody used was 100 % reactive to human NPY, and had 0 % and 3 % cross reactivity to, respectively, human PYY and pancreatic polypeptide. The possibility of impaired renal excretion or degradation leading to high plasma concentration was considered, but rejected for two reasons: Firstly, despite the fact that kidney contributes to peptide hormone clearance, 12-40%, mostly by tubular uptake and degradation (21, 15, 34) , not all peptides are increased in renal failure. This is because high plasma concentration should evoke a negative feedback decline in secretion. Secondly, there is a striking lack of parallel increments in peptide hormones in the ESRD population. When an increased level is noted, there is usually a component of increased production; decreased renal excretion or degradation plays a minor role. Examples to support this contention include the following: Elevation of leptin and insulin is found mostly in patients with high body fat, high parathyroid hormone in those with renal osteodystrophy, increased gonadotropins in postmenopausal women, and high TSH in hypothyroid subjects. More pertinently, kinetic study of prolactin, modestly elevated in CRF patients, illustrated unequivocally increased production (35) .
In control subjects, the circadian rhythm of NPY was reciprocal to that of leptin. It peaked between 08 to 09 hour when daily eating began and reached nadir values about 00 to 04 hours when eating had ceased. This pattern is consistent with the current view that high leptin suppresses NPY. In the CRF patients, circadian NPY variation was remarkably muted; the diurnal curve was almost flat and circulating NPY levels were constantly elevated. [ Table 3 and Figure 2B ]. Of interest is the finding that fasting not only failed to increase NPY peaks, but actually accentuated the 00-04 hour nadir [ Figure 2A] . As NPY is a potent orexigenic peptide, teleologically, one would expect it to rise during fasting (28). In rodents, fasting does increase NPY gene expression in the central nervous system (5). But NPY is not the only peptide responsible for increased eating during fast. Other pathways stimulate eating equally well. The fact that parallel and redundant pathways exist in stimulating food acquisition is well illustrated in NPY knockout mice that maintain normal eating habit and body weight (9).
NPY is not just an orexigenic peptide, but has far greater physiologic role. It is a vasoactive peptide that is widely distributed in the central and the peripheral nervous systems. In the central nervous system, it inhibits sympathetic pre-ganglionic neurons leading to a reduction in thermogenesis of brown adipose tissue (4, 17) . Centrally, NPY stimulates corticosterone secretion in rats, an effect mediated through the hypothalamus because corticotropin-releasing factor and ACTH secretion are both increased (30). In the periphery, NPY is co-released with norepinephrine during sympathetic nerve stimulation. It enhances vasoconstriction and modulates cardiac function (23, 25) . Zoccali et al recently reported elevated circulating NPY in CRF patients, showing a direct relationship between plasma NPY and norepinephrine and epinephrine (38) . More importantly, elevated NPY predicts higher mortality from cardiovascular events. Chronic renal failure is accompanied by a heightened sympathetic state, and the high serum NPY may reflect this (7).
Glucocorticoid and insulin have been known for a long time to play important roles in eating and energy balance. The two hormones have reciprocal effects. In the central nervous system, glucocorticoid stimulates while insulin inhibits eating, acting through stimulation and inhibition of NPY, respectively (37). By contrast, in the periphery, glucocorticoid is catabolic, and insulin, anabolic with regard to energy storage. Adrenalectomy cures obesity of all origins, diet-induced, hypothalamic disorder or genetic aberration (29). This is due to a combination of cortisol deficiency and high corticotripin-releasing hormone secretion. While cortisol stimulates eating, corticotripin-releasing hormone is an anorexigenic peptide (12). In our renal failure patients, cortisol physiology was altered. There was a loss of evening hour cortisol suppression and ACTH tended to be higher; the latter suggests that the apparent hypercortisol state was hypothalamic in origin. The reason for the higher ACTH is not understood, it could be related to the high NPY state. In mammals, cortisol and NPY exhibit a positive feedback relationship (1). As for eating, the hypercortisol state tends to override the effect of high corticotropinreleasing hormone. With regard to insulin, renal failure patients had higher plasma insulin levels at all times, but their responses to fasting and feeding were identical to those of normal subjects. Fasting resulted in insulin suppression, which should stimulate eating. More importantly, feeding led to a remarkable increase in insulin secretion; the latter, making anabolism possible (19).
A note should be made regarding the lower protein intake in the CRF patients, 0.89 g/kg/day. This lower intake was due, in part, to impose phosphorus restriction, and is unlikely to cause neuroendocrine disturbance. In the non-Western World, most population consume less than this amount of protein. It is important to emphasize that we have shown repeatedly, with whole-body in-vivo amino acid kinetics, that this amount of protein intake, in the absence of any catabolic event, is perfectly adequate to maintain nitrogen and protein balance (20) .
This work has limitation, most importantly are the small number of study subjects combined with the heterogenous nature of the CRF group consisting of pre-dialysis, hemodialysis and peritoneal dialysis patients. Fortunately, the observed responses to the experimental maneuver were qualitatively similar in most subjects. Quantitatively, any difference noted appeared to be related to body fat mass, and not uremia or the modality of treatment. Despite the limitations, this study demonstrated that the maneuver of fasting and refeeding provides a tool that can be used effectively for further study.
In summary, new information derived from this study regarding eating and energy balance in CRF patients includes: [1] Anorexia, if present, was unlikely to be due to excess leptin or insufficient NPY. [2] Leptin response to fasting and eating were similar in the two study groups; fasting suppressed leptin and feeding resulted in a nocturnal surge. [3] There was a tonic hypersecretion of NPY in CRF patients, possibly related to heightened sympathetic state. [4] A hypercorticoid state was present in CRF patients as evident by impaired cortisol suppression in the evening hours. The high cortisol level should, however, favor eating. [5] Fasting effectively suppressed and eating briskly stimulated insulin secretion to similar magnitude in controls and CRF patients. These responses favor eating when energy balance is low and anabolism when energy intake is abundant. [6] CRF patients responded appropriately to fasting with hunger and increased desire to eat. Despite the prevailing view that uremic patients are anorexic, we found that our CRF subjects responded to fasting with appropriate sense of hunger and desire to eat, and, in fact, ate well after fasting. Another new observation, found in both study groups, was the failure of NPY to rise during fasting despite marked leptin suppression.
The relatively normal pattern of the appetite-related hormones found in this study may be due to the fact that we screened our study patients vigorously to exclude those with concomitant illnesses and they are healthier than the general ESRD population. It should be emphasized that we have not evaluated the melanocortin pathways; increased α-MSH secretion or enhanced activity of the melanocortin-4 receptor binding inhibits eating and increases thermogenesis (10, 22) . We have also have not studied the gherlin and PYY [peptide YY] system, the former is secreted by the stomach to stimulate eating, and the latter, secreted by the large intestine and suppresses appetite (24, 2) . We also have not assessed other orexigenic peptides including the melanin-concentrating hormone, the agouti-related peptide or the newly discovered orexins (6, 10, 31) .
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